182 related articles for article (PubMed ID: 22401581)
1. IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors.
Regel I; Eichenmüller M; Joppien S; Liebl J; Häberle B; Müller-Höcker J; Vollmar A; von Schweinitz D; Kappler R
Mol Cancer; 2012 Mar; 11():9. PubMed ID: 22401581
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by IGFBP3 overexpression in hepatocellular carcinoma cells.
Han JJ; Xue DW; Han QR; Liang XH; Xie L; Li S; Wu HY; Song B
Asian Pac J Cancer Prev; 2014; 15(23):10085-9. PubMed ID: 25556430
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of
Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
[TBL] [Abstract][Full Text] [Related]
4. Functional modulation of IGF-binding protein-3 expression in melanoma.
Dar AA; Majid S; Nosrati M; de Semir D; Federman S; Kashani-Sabet M
J Invest Dermatol; 2010 Aug; 130(8):2071-9. PubMed ID: 20357812
[TBL] [Abstract][Full Text] [Related]
5. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
6. Amyloid beta-mediated epigenetic alteration of insulin-like growth factor binding protein 3 controls cell survival in Alzheimer's disease.
Sung HY; Choi EN; Lyu D; Mook-Jung I; Ahn JH
PLoS One; 2014; 9(6):e99047. PubMed ID: 24964199
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of IGFBP3 is associated with poor prognosis and tumor metastasis in nasopharyngeal carcinoma.
Bao L; Liu H; You B; Gu M; Shi S; Shan Y; Li L; Chen J; You Y
Tumour Biol; 2016 Nov; 37(11):15043-15052. PubMed ID: 27658775
[TBL] [Abstract][Full Text] [Related]
8. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
Ibanez de Caceres I; Dulaimi E; Hoffman AM; Al-Saleem T; Uzzo RG; Cairns P
Cancer Res; 2006 May; 66(10):5021-8. PubMed ID: 16707423
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
11. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
12. The insulin-like growth factor binding proteins 3 and 7 are associated with colorectal cancer and liver metastasis.
Georges RB; Adwan H; Hamdi H; Hielscher T; Linnemann U; Berger MR
Cancer Biol Ther; 2011 Jul; 12(1):69-79. PubMed ID: 21525788
[TBL] [Abstract][Full Text] [Related]
13. Blocking the hedgehog pathway inhibits hepatoblastoma growth.
Eichenmüller M; Gruner I; Hagl B; Häberle B; Müller-Höcker J; von Schweinitz D; Kappler R
Hepatology; 2009 Feb; 49(2):482-90. PubMed ID: 19177589
[TBL] [Abstract][Full Text] [Related]
14. Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.
Honda S; Arai Y; Haruta M; Sasaki F; Ohira M; Yamaoka H; Horie H; Nakagawara A; Hiyama E; Todo S; Kaneko Y
Br J Cancer; 2008 Dec; 99(11):1891-9. PubMed ID: 19034281
[TBL] [Abstract][Full Text] [Related]
15. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
16. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
[TBL] [Abstract][Full Text] [Related]
18. Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation.
Hanafusa T; Shinji T; Shiraha H; Nouso K; Iwasaki Y; Yumoto E; Ono T; Koide N
BMC Cancer; 2005 Jan; 5():9. PubMed ID: 15661074
[TBL] [Abstract][Full Text] [Related]
19. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma.
Ye P; Qu CF; Hu XL
Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-binding protein-3 promotes transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells.
Natsuizaka M; Ohashi S; Wong GS; Ahmadi A; Kalman RA; Budo D; Klein-Szanto AJ; Herlyn M; Diehl JA; Nakagawa H
Carcinogenesis; 2010 Aug; 31(8):1344-53. PubMed ID: 20513670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
